Medtronic Vascular, Inc. et al v. Boston Scientific Corp et al, No. 2:06-cv-00078 (E.D. Tex. Aug. 29, 2008)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

I. BACKGROUND In this case, plaintiffs Medtronic Vascular, Inc., Medtronic USA, Inc., Medronic Inc., and Medtronic Vascular Galway (collectively, “Medtronic,” “Bard,” or “pl aintiffs”) obtained a jur y1 verdict of infringement against defendants Boston Scientific Corp., Scimed Life Systems, Inc. and Boston Scientific Scimed, Inc. (collectively, “BSC” or “defendants”) with respect to United States Patent Nos. 6,190,358 (“the ‘358 patent”), 6,605,057 (“the ‘057 patent”), and 6,210,364 (“the ‘364 patent”). See Dkt. No. 213 (Jury Verdict).